Rethinking Endpoints in Chronic Hepatitis B Treatment

IN A NEW expert analysis, hepatology researchers are calling for a strategic shift in how clinical trials and clinicians define successful treatment for chronic hepatitis B (CHB). While complete loss of hepatitis B surface antigen (HBsAg),…